|
Status |
Public on Jan 14, 2018 |
Title |
Clostridium difficile response to oxygen |
Platform organism |
Clostridioides difficile |
Sample organism |
Clostridioides difficile 630 |
Experiment type |
Expression profiling by array
|
Summary |
C. difficile was grown in either anaerobic conditions or 2% oxygen and gene expression was compared
|
|
|
Overall design |
C. difficile was grown in either anaerobic conditions or 2% oxygen and gene expression was compared. Two conditions were tested with three replicates each (6 samples total)
|
|
|
Contributor(s) |
Carlson PE Jr |
Citation(s) |
29390060 |
|
Submission date |
Jan 13, 2018 |
Last update date |
Apr 19, 2018 |
Contact name |
Paul Carlson |
E-mail(s) |
paul.carlson@fda.hhs.gov
|
Organization name |
Food and Drug Administration
|
Department |
DBPAP
|
Lab |
LMPCI
|
Street address |
10903 New Hampshire Ave
|
City |
Silver Spring |
State/province |
MD |
ZIP/Postal code |
20993 |
Country |
USA |
|
|
Platforms (1) |
GPL24513 |
Carlson/FDA - Clostridium difficile 630 - 15k |
|
Samples (6)
|
GSM2934763 |
Clostridium difficile - anaerobic - Replicate 1 |
GSM2934764 |
Clostridium difficile - anaerobic - Replicate 2 |
GSM2934765 |
Clostridium difficile - anaerobic - Replicate 3 |
GSM2934766 |
Clostridium difficile - 2% oxygen - Replicate 1 |
GSM2934767 |
Clostridium difficile - 2% oxygen - Replicate 2 |
GSM2934768 |
Clostridium difficile - 2% oxygen - Replicate 3 |
|
Relations |
BioProject |
PRJNA429922 |